| Effect of Iressa With/Without Concurrent Chemoradiotherapy on Tumor Gene Expression Profiles in Patients With Advanced Non-Nasopharyngeal Head and Neck Carcinoma (NCT00228488) | AstraZeneca | 2004-06-01 |
| A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients Without Erosive Esophagitis. (NCT00206284) | AstraZeneca | 2004-05-01 |
| Dose Response Study in Japanese Patients (NCT00261417) | AstraZeneca | 2004-05-01 |
| Efficacy and Safety of Roflumilast in Japanese Patients With Bronchial Asthma (20 to 70 y) (APTA-2217-05). (NCT00242307) | AstraZeneca | 2004-05-01 |
| Chest Pain Pilot Study (NCT00251901) | AstraZeneca | 2004-05-01 |
| A Trial to Evaluate the Combination of Iressa & Faslodex® in Patients With Advanced or Metastatic Breast Cancer (NCT00234403) | AstraZeneca | 2004-05-01 |
| ASTERIX: Low Dose ASA and Nexium (NCT00251966) | AstraZeneca | 2004-05-01 |
| A Phase I Study of ZD1839 and Palliative Thoracic Radiotherapy in Patients With Non-small-cell Lung Cancer (NCT00255489) | AstraZeneca | 2004-05-01 |
| Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin (NCT00099320) | AstraZeneca | 2004-05-01 |
| SOLO-Symbicort® in the Treatment of Persistent Asthma in Adolescents & Adults (NCT00238784) | AstraZeneca | 2004-05-01 |
| Safety and Effectiveness of Ciclesonide Nasal Spray in Children (6 to 11 Years) With Perennial Allergic Rhinitis (BY9010/M1-403) (NCT00163514) | AstraZeneca | 2004-05-01 |
| A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis. (NCT00206245) | AstraZeneca | 2004-05-01 |
| DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines (NCT00233649) | AstraZeneca | 2004-05-01 |
| Efficacy and Safety of Roflumilast Taken in the Morning or Evening in Patients With Stable Asthma (12 to 70 y) (BY217/M2-015) (NCT00163475) | AstraZeneca | 2004-05-01 |
| Faslodex 500mg Multiple Dose Tolerability Study in BC Patients (NCT00328120) | AstraZeneca | 2004-04-01 |
| Seroquel on Glucose Metabolism (NCT00214578) | AstraZeneca | 2004-04-01 |
| SHARE - Symbicort and Health Economics in a Real Life Evaluation (NCT00259766) | AstraZeneca | 2004-04-01 |
| Pharmacodynamic/Pharmacokinetic Interactions Between Oral Roflumilast and Inhaled Formoterol (NCT00940329) | AstraZeneca | 2004-04-01 |
| Anti-tumour Effects & Tolerability of Faslodex Alone or in Combination With Arimidex in Post Menopausal Women Prior to Surgery for Primary Breast Cancer (NCT00259090) | AstraZeneca | 2004-04-01 |
| Anastrozole Biphosphonate Study in Postmenopausal Women With Hormone-Receptor-Positive Early Breast Cancer (NCT00082277) | AstraZeneca | 2004-04-01 |
| A Study to Investigate the Effect of Rosuvastatin (CRESTOR®) on High Density Lipoprotein Kinetics in Patients With the Metabolic Syndrome (NCT00240305) | AstraZeneca | 2004-04-01 |
| Phase I AZD2171 in Patients With Relapsed or Refractory AML and Elderly Patients With DeNovo or Secondary AML (NCT00502385) | AstraZeneca | 2004-04-01 |
| Assess the Efficacy and Safety of Rhinocort Aqua (NCT00641693) | AstraZeneca | 2004-04-01 |
| Efficacy & Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder (NCT00107731) | AstraZeneca | 2004-04-01 |
| Effect of Budesonide / Formoterol Combination in Repeated AMP Provocations (NCT00272753) | AstraZeneca | 2004-04-01 |
| Efficacy and Safety of Seroquel Plus Mood Stabilizer in the Maintenance of Bipolar I Disorder (NCT00081380) | AstraZeneca | 2004-03-01 |
| CP-675,206 With Neoadjuvant Hormone Therapy in Patients With High Risk Prostate Cancer (NCT00075192) | AstraZeneca | 2004-03-01 |
| Study to Assess Safety and Tolerability of AZD2171 After Multiple Doses in Patients With Advanced Prostate Cancer (NCT00502164) | AstraZeneca | 2004-03-01 |
| Secondary Adjuvant Long Term Study With Arimidex (NCT00295620) | AstraZeneca | 2004-03-01 |
| The IRESSA Novel Head and Neck Chemotherapy Evaluation Study (NCT00255476) | AstraZeneca | 2004-02-01 |
| A Study of ZD1839 Effects on Cell Proliferation in Breast Cancer (NCT00252811) | AstraZeneca | 2004-02-01 |
| Iressa Versus Docetaxel (Taxotere) (NCT00076388) | AstraZeneca | 2004-02-01 |
| Dutch Sub Study: Controlled Rosuvastatin Multinational Study in Heart Failure (CORONA). PET Sub Study (NCT00228514) | AstraZeneca | 2004-02-01 |
| Study of the Safety of Substituting Exenatide for Insulin in Patients Using Insulin and Oral Antidiabetic Agents (NCT00099333) | AstraZeneca | 2004-02-01 |
| Safety of Daily Dose Esomeprazole for GERD for Pediatric and Adolescent Patients (NCT00241501) | AstraZeneca | 2004-02-01 |
| IRESSA™ In Combo With Xeloda™ in Advanced Colorectal Cancer Patients After 1st-Line Chemo Failure (NCT00242788) | AstraZeneca | 2004-02-01 |
| Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck Cancer (NCT00681967) | AstraZeneca | 2004-02-01 |
| Electronic Study for Anastrozole Pharmacovigilance Evaluation (NCT00558168) | AstraZeneca | 2004-01-01 |
| Iressa vs Placebo as Maintenance Therapy in Locally Advanced NSCLC (NCT00234468) | AstraZeneca | 2004-01-01 |
| A Study to Investigate the Pharmacodynamic Effect After Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population (NCT00259051) | AstraZeneca | 2004-01-01 |
| Efficacy of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-137) (NCT00163397) | AstraZeneca | 2004-01-01 |
| Anastrozole Monotherapy Versus Maximal Oestrogen Blockade With Anastrozole and Fulvestrant Combination Therapy (NCT00256698) | AstraZeneca | 2004-01-01 |
| Assessment of the Lipid Lowering Effect of Rosuvastatin Compared to Atorvastatin in Subjects With Coronary Heart Disease (NCT00235950) | AstraZeneca | 2004-01-01 |
| Long Term Safety & Efficacy of Budesonide Inhalation Suspension in Japanese Children With Bronchial Asthma (NCT00232648) | AstraZeneca | 2004-01-01 |
| Comparing Anastrozole-Placebo to the Combination Anastrozole-ZD1839 in Postmenopausal Patients With Estrogen Receptor and/or Progesterone Receptor Metastatic Breast Cancer (NCT00077025) | AstraZeneca | 2004-01-01 |
| Phase II Neoadjuvant ER+/PgR + Arimidex +/- Iressa Study (NCT00255463) | AstraZeneca | 2004-01-01 |
| Effectiveness of Ciclesonide Versus Budesonide in Patients With Asthma (18 to 75 y) (BY9010/M1-136) (NCT00163384) | AstraZeneca | 2004-01-01 |
| Safety and Effectiveness of Ciclesonide Nasal Spray in Patients With Perennial Allergic Rhinitis During One Year Treatment (BY9010/M1-404) (NCT00163501) | AstraZeneca | 2003-12-01 |
| Addition of Quetiapine in Obsessive Compulsive Disorder - Westenberg Study (NCT00318539) | AstraZeneca | 2003-12-01 |
| An Open-Label Study Examining the Long-Term Safety of Exenatide Given Twice Daily to Patients With Type 2 Diabetes Mellitus (NCT01876849) | AstraZeneca | 2003-12-01 |
| The FLASH Study: A Study of Roflumilast Versus Placebo in Patients With Asthma (BY217/M2-023) (NCT00076076) | AstraZeneca | 2003-12-01 |
| LUNAR IIIb Study Comparing Rosuvastatin and Atorvastatin in Subjects With Acute Coronary Syndromes (NCT00214630) | AstraZeneca | 2003-12-01 |
| OPUS Study: Effect of Roflumilast on Exacerbation Rate in Patients With Chronic Obstructive Pulmonary Disease (BY217/M2-111) (NCT00076089) | AstraZeneca | 2003-12-01 |
| To Assess the Safety and Efficacy of Ciclesonide Applied as a Nasal Spray in the Treatment of Perennial Allergic Rhinitis (BY9010/M1-402) (NCT00659750) | AstraZeneca | 2003-12-01 |
| Combination Casodex® and Iressa™ in Locally Advanced Prostate Cancer (NCT00319787) | AstraZeneca | 2003-12-01 |
| Gefitinib in the Treatment of the First Relapse of Prostate Cancer Beyond Prostatectomy or Radiotherapy (NCT00241475) | AstraZeneca | 2003-12-01 |
| To Assess the Safety and Efficacy of Ciclesonide, Applied as a Nasal Spray in the Treatment of Seasonal Allergic Rhinitis (BY9010/M1-401) (NCT00659841) | AstraZeneca | 2003-12-01 |
| Two Different Regimens of Nolvadex in Preventing Gynecomastia Induced by Casodex 150 mg in Patients With Prostate Cancer (NCT00233610) | AstraZeneca | 2003-12-01 |
| A Phase 2 Study of Tomudex & Iressa as Second Line Chemotherapy in Subjects With Colorectal Carcinoma (NCT00234429) | AstraZeneca | 2003-11-01 |
| Esomeprazole In Patients With Gastric Acid Hypersecretory States Including Idiopathic Hypersecretion and Zollinger-Ellison Syndrome (NCT00079833) | AstraZeneca | 2003-11-01 |
| Head and Neck Phase III Iressa Versus Methotrexate Refractory: Iressa Versus Methotrexate (IMEX) (NCT00206219) | AstraZeneca | 2003-11-01 |
| PULSAR - A Prospective Study to Evaluate the Utility of Low Doses of the Statins Atorvastatin and Rosuvastatin. (NCT00329173) | AstraZeneca | 2003-11-01 |
| Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin (NCT00082407) | AstraZeneca | 2003-11-01 |
| Iressa Case Control Study in Japan (NCT00252759) | AstraZeneca | 2003-11-01 |
| Efficacy and Safety of Roflumilast in Patients With Asthma (BY217/M2-012) (NCT00073177) | AstraZeneca | 2003-11-01 |
| Atlantis Symbicort (NCT00646594) | AstraZeneca | 2003-11-01 |
| Seroquel STACK Study in Schizophrenic or Schizoaffective Subjects (NCT00328978) | AstraZeneca | 2003-10-01 |
| Four-week Omeprazole Treatment of Non-erosive Reflux Disease in a Japanese Population (NCT00259077) | AstraZeneca | 2003-10-01 |
| Gemini Symbicort pMDI (NCT00646516) | AstraZeneca | 2003-10-01 |
| Phase II Metastatic ER+/PgR+ Nolvadex +/- Iressa Study (NCT00229697) | AstraZeneca | 2003-10-01 |
| Atacand Dose Range Finding Study in Pediatric Subjects 6 to <17 Years of Age (NCT00244634) | AstraZeneca | 2003-09-01 |
| Crestor Versus Placebo in Subjects With Heart Failure (NCT00206310) | AstraZeneca | 2003-09-01 |
| Safety, Tolerability and Efficacy of ZD6126 in Combination With Oxaliplatin, 5-Fluorouracil and Leucovorin in Subjects With Metastatic Colorectal Cancer. (NCT00065117) | AstraZeneca | 2003-09-01 |
| A Study of the Cataractogenic Potential of Seroquel and Risperdal in the Treatment of Participants With Schizophrenia or Schizoaffective Disorder (NCT00206102) | AstraZeneca | 2003-09-01 |
| An Open-label, Phase II Trial of ZD1839 (IRESSA) in Patients With Malignant Mesothelioma (NCT00787410) | AstraZeneca | 2003-09-01 |
| Effect of Exenatide Monotherapy on Glucose Control in Subjects With Type 2 Diabetes Mellitus (NCT00085969) | AstraZeneca | 2003-09-01 |
| Efficacy of Ciclesonide on Small Airways in Patients With Stable Asthma (18 to 60 y) (BY9010/M1-131) (NCT00163345) | AstraZeneca | 2003-09-01 |
| Efficacy, Safety, & Pharmacokinetics of Candesartan Cilexetil in Hypertensive Paediatric Subjects 6 to < 17 Years of Age (NCT00244595) | AstraZeneca | 2003-09-01 |
| Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132) (NCT00163358) | AstraZeneca | 2003-09-01 |
| Symbicort Single Inhaler Therapy for Asthma in a General Practice Setting (NCT00235911) | AstraZeneca | 2003-09-01 |
| Iressa 2nd Line Phase III Study in Japan (NCT00252707) | AstraZeneca | 2003-09-01 |
| Evaluation of the Efficacy of Rosuvastatin in Daily Practice in Untreated High Risk Patients (CHALLENGE) (NCT00574782) | AstraZeneca | 2003-09-01 |
| Exploratory Study to Assess the Biological Activity of ZD6126 in Subjects With Newly Diagnosed Metastatic Renal Cell Carcinoma (Stage IV) (NCT00065572) | AstraZeneca | 2003-08-01 |
| CP-675,206 In Patients With Advanced Melanoma (NCT00086489) | AstraZeneca | 2003-08-01 |
| Titratable Dosing in Moderate to Severe Asthmatics (NCT00651768) | AstraZeneca | 2003-08-01 |
| The Evaluation of the Efficacy and Tolerability of FASLODEX (Fulvestrant) and AROMASIN (Exemestane) in Hormone Receptor Positive Postmenopausal Women With Advanced Breast Cancer (NCT00065325) | AstraZeneca | 2003-08-01 |
| Study of High Density Lipoprotein Cholesterol (HDL-C)-Raising Mechanism of Rosuvastatin (CRESTOR™) by Quantifying the Key Steps of Reverse Cholesterol Transport (RCT) (NCT00240266) | AstraZeneca | 2003-08-01 |
| Effect of AC2993 With or Without Immunosuppression on Beta Cell Function in Patients With Type I Diabetes (NCT00064714) | AstraZeneca | 2003-07-01 |
| Iressa vs Best Supportive Care - 2nd/3rd Line Survival Study (NCT00242801) | AstraZeneca | 2003-07-01 |
| ZD1839 (IRESSA™) in Combination With Docetaxel & Cisplatin in Subjects With Metastatic Head & Neck Cancer (NCT00242762) | AstraZeneca | 2003-07-01 |
| Iressa and Radiotherapy in the Treatment of the Locally Advanced Inoperable Squamous Cell Carcinoma of the Head and Neck (NCT00233636) | AstraZeneca | 2003-07-01 |
| Gefitinib in Combination With Chemoradiation in Resectable Gastric Cancer (NCT00237900) | AstraZeneca | 2003-07-01 |
| Ph II Early BC Pre-Surgical Biologic Study (NCT00637026) | AstraZeneca | 2003-07-01 |
| Dose Finding of Quetiapine Fumarate 200mg vs 400mg in First Episode Psychosis (NCT00449397) | AstraZeneca | 2003-07-01 |
| Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke (NCT00119626) | AstraZeneca | 2003-06-01 |
| A Phase IIa. Open-label, Multicenter, Dose-escalation Study to Assess the Tolerability and Pharmacokinetics of ZD4054 (Zibotentan) Given Orally Once Daily in Subjects With Metastatic Prostate Cancer (NCT00055471) | AstraZeneca | 2003-06-01 |
| Effect of Roflumilast on Pulmonary Function and Respiratory Symptoms in Patients With Chronic Obstructive Pulmonary Disease (COPD) (BY217/M2-110) (NCT00062582) | AstraZeneca | 2003-06-01 |
| Combination Weekly Taxotere™ With Iressa™ /Placebo in Metastatic Breast Cancer (NCT00319618) | AstraZeneca | 2003-06-01 |
| Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy (NCT00239330) | AstraZeneca | 2003-06-01 |
| DISCOVERY Asia - Crestor in Type IIa and IIb Hypercholesteremia (NCT00241488) | AstraZeneca | 2003-06-01 |